Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat.
暂无分享,去创建一个
[1] D. Rasmusson,et al. The role of basal forebrain neurons in tonic and phasic activation of the cerebral cortex , 1999, Progress in Neurobiology.
[2] R. McCarley,et al. Excitatory amino acid-mediated responses and synaptic potentials in medial pontine reticular formation neurons of the rat in vitro , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[3] A. Kales,et al. The Pharmacology of Sleep , 1995, Handbook of Experimental Pharmacology.
[4] J. Monti. Pharmacology of the histaminergic system , 1995 .
[5] J. Monti,et al. 5-HT receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and 8-OH-DPAT increase wakefulness in the rat , 1990 .
[6] A I Pack,et al. Serotonin at the Laterodorsal Tegmental Nucleus Suppresses Rapid-Eye-Movement Sleep in Freely Behaving Rats , 1997, The Journal of Neuroscience.
[7] R. McCarley,et al. Behavioral State Control through Differential Serotonergic Inhibition in the Mesopontine Cholinergic Nuclei: A Simultaneous Unit Recording and Microdialysis Study , 1998, The Journal of Neuroscience.
[8] F. Hery,et al. The role of serotonin release and autoreceptors in the dorsalis raphe nucleus in the control of serotonin release in the cat caudate nucleus , 1990, Neuroscience.
[9] J. Parnavelas. Neurotransmitters in the cerebral cortex. , 1990, Progress in brain research.
[10] Mark C. Jones. PRINCIPLES AND PRACTICE OF SLEEP MEDICINE , 1990 .
[11] C. Dugovic,et al. 5-HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat. , 1987, European journal of pharmacology.
[12] F. Artigas,et al. Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[13] L. Sanford,et al. Central administration of two 5-HT receptor agonists: Effect on REM sleep initiation and PGO waves , 1994, Pharmacology Biochemistry and Behavior.
[14] D. Monti,et al. Role of dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of REM sleep. , 2000, Life sciences.
[15] K. Semba,et al. Serotonergic synaptic input to cholinergic neurons in the rat mesopontine tegmentum , 1994, Brain Research.
[16] D. Monti,et al. Effects of selective activation of the 5-HT1B receptor with CP-94,253 on sleep and wakefulness in the rat , 1995, Neuropharmacology.
[17] J. Monti. Catecholamines and the sleep-wake cycle. I. EEG and behavioral arousal. , 1982, Life sciences.
[18] Dennis S. Charney,et al. Neuropsychopharmacology : The Fifth Generation of Progress , 2002 .
[19] J A Hobson,et al. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. , 1975, Science.
[20] M. Tohyama,et al. Atlas of Neuroactive Substances and Their Receptors in the Rat , 1998 .
[21] K. Semba,et al. Aminergic and cholinergic afferents to REM sleep induction regions of the pontine reticular formation in the rat , 1993, The Journal of comparative neurology.
[22] Mustapha Riad,et al. Immunocytochemical localization of serotonin1A receptors in the rat central nervous system , 1996, The Journal of comparative neurology.
[23] R. Stickgold,et al. The neuropsychology of REM sleep dreaming. , 1998, Neuroreport.
[24] Carl W. Bazil,et al. Sleep and epilepsy : the clinical spectrum , 2002 .
[25] B. Bjorvatn,et al. Sleep/waking effects of a selective 5-HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats , 1997, Brain Research.
[26] J. Monti,et al. The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat. , 1993, European journal of pharmacology.
[27] P. Grof,et al. An open study of oral flesinoxan, a 5‐HT1A receptor agonist, in treatment‐resistant depression , 1993, International clinical psychopharmacology.
[28] S. Mori,et al. Extracellular levels of serotonin in the medial pontine reticular formation in relation to sleep-wake cycle in cats: a microdialysis study , 1993, Neuroscience Research.
[29] Amygdaloid control of alerting and behavioral arousal in rats: involvement of serotonergic mechanisms. , 1995, Archives italiennes de biologie.
[30] Winni F. Hofman,et al. Sleep-wake research in the Netherlands , 1999 .
[31] R. McCarley,et al. Behavioral state-related changes of extracellular serotonin concentration in the pedunculopontine tegmental nucleus: a microdialysis study in freely moving animals. , 1999, Sleep research online : SRO.
[32] Gilles Bonvento,et al. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain , 1992, Neuroscience Letters.
[33] J. Monti,et al. Dose‐dependent effects of the 5‐HT1A receptor agonist 8‐OH‐DPAT on sleep and wakefulness in the rat , 1992, Journal of sleep research.
[34] D. Monti,et al. Increased REM sleep after intra-dorsal raphe nucleus injection of flesinoxan or 8-OHDPAT: prevention with WAY 100635 , 2002, European Neuropsychopharmacology.
[35] J. Monti,et al. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat , 2004, Psychopharmacology.
[36] M. Hamon,et al. Ultrastructural localization of 5‐hydroxytryptamine1A receptors in the rat brain , 1996, Journal of neuroscience research.
[37] D. Rainnie,et al. Microdialysis perfusion of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH- DPAT) in the dorsal raphe nucleus decreases serotonin release and increases rapid eye movement sleep in the freely moving cat , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[38] R. Vertes,et al. Projections of the dorsal raphe nucleus to the brainstem: PHA‐L analysis in the rat , 1994, The Journal of comparative neurology.
[39] J. Leysen,et al. 5-HT7 receptors: current knowledge and future prospects. , 2000, Trends in pharmacological sciences.